BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Y, Zhu G, Dong B, Piao J, Chen L, Lin Z. The NQO1/PKLR axis promotes lymph node metastasis and breast cancer progression by modulating glycolytic reprogramming. Cancer Lett 2019;453:170-83. [PMID: 30954648 DOI: 10.1016/j.canlet.2019.03.054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu K, Deng C, Du P, Liu T, Piao J, Piao Y, Yang M, Chen L. G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo. Reprod Biol Endocrinol 2022;20:50. [PMID: 35277194 DOI: 10.1186/s12958-022-00921-6] [Reference Citation Analysis]
2 Yan Z, Yan Q, Song Y, Wang L. TMSB10, a potential prognosis prediction biomarker, promotes the invasion and angiogenesis of gastric cancer. J Gastroenterol Hepatol 2021. [PMID: 34114679 DOI: 10.1111/jgh.15576] [Reference Citation Analysis]
3 Wei Q, Qian Y, Yu J, Wong CC. Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications. Oncogene. 2020;39:6139-6156. [PMID: 32839493 DOI: 10.1038/s41388-020-01432-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
4 Lin J, Xia L, Liang J, Han Y, Wang H, Oyang L, Tan S, Tian Y, Rao S, Chen X, Tang Y, Su M, Luo X, Wang Y, Wang H, Zhou Y, Liao Q. The roles of glucose metabolic reprogramming in chemo- and radio-resistance. J Exp Clin Cancer Res 2019;38:218. [PMID: 31122265 DOI: 10.1186/s13046-019-1214-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 16.3] [Reference Citation Analysis]
5 Qiao D, Xing J, Duan Y, Wang S, Yao G, Zhang S, Jin J, Lin Z, Chen L, Piao Y. The molecular mechanism of baicalein repressing progression of gastric cancer mediating miR-7/FAK/AKT signaling pathway. Phytomedicine 2022;100:154046. [DOI: 10.1016/j.phymed.2022.154046] [Reference Citation Analysis]
6 Hipólito A, Martins F, Mendes C, Lopes-Coelho F, Serpa J. Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis. Front Oncol 2021;11:656851. [PMID: 34150624 DOI: 10.3389/fonc.2021.656851] [Reference Citation Analysis]
7 Guo Y, Xu L, Ling C, Yang T, Zheng W, Lv J, Guo Q, Chen B. Novel β‐carboline‐based indole‐4,7‐quinone derivatives as NAD(P)H: Quinone‐oxidoreductase‐1 inhibitor with potent antitumor activities by inducing reactive oxygen species, apoptosis, and DNA damage. Chem Biol Drug Des 2020;96:1433-46. [DOI: 10.1111/cbdd.13752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Wang S, Zhang Y, Cai Q, Ma M, Jin LY, Weng M, Zhou D, Tang Z, Wang JD, Quan Z. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression. Mol Cancer 2019;18:145. [PMID: 31623628 DOI: 10.1186/s12943-019-1078-z] [Cited by in Crossref: 52] [Cited by in F6Publishing: 61] [Article Influence: 17.3] [Reference Citation Analysis]
9 Zhu K, Li Y, Deng C, Wang Y, Piao J, Lin Z, Chen L. Significant association of PKM2 and NQO1 proteins with poor prognosis in breast cancer. Pathol Res Pract 2020;216:153173. [PMID: 32841776 DOI: 10.1016/j.prp.2020.153173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Haque E, Teeli AS, Winiarczyk D, Taguchi M, Sakuraba S, Kono H, Leszczyński P, Pierzchała M, Taniguchi H. HNF1A POU Domain Mutations Found in Japanese Liver Cancer Patients Cause Downregulation of HNF4A Promoter Activity with Possible Disruption in Transcription Networks. Genes 2022;13:413. [DOI: 10.3390/genes13030413] [Reference Citation Analysis]
11 Liu W, Wu J, Ji X, Ma Y, Liu L, Zong X, Yang H, Dai J, Chen X, Xue W. Advanced biomimetic nanoreactor for specifically killing tumor cells through multi-enzyme cascade. Theranostics 2020;10:6245-60. [PMID: 32483451 DOI: 10.7150/thno.45456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
12 Pradubyat N, Sakunrangsit N, Mutirangura A, Ketchart W. NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells. Phytomedicine 2020;66:153133. [PMID: 31790893 DOI: 10.1016/j.phymed.2019.153133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sun X, Wang M, Wang M, Yao L, Li X, Dong H, Li M, Li X, Liu X, Xu Y. Exploring the Metabolic Vulnerabilities of Epithelial-Mesenchymal Transition in Breast Cancer. Front Cell Dev Biol 2020;8:655. [PMID: 32793598 DOI: 10.3389/fcell.2020.00655] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
14 Huang W, Shi G, Yong Z, Li J, Qiu J, Cao Y, Zhao Y, Yuan L. Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p. Cell Death Dis 2020;11:504. [PMID: 32632129 DOI: 10.1038/s41419-020-2695-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
15 Fan Z, Fan K, Deng S, Gong Y, Qian Y, Huang Q, Yang C, Cheng H, Jin K, Luo G, Liu C, Yu X. HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR. Acta Biochim Biophys Sin (Shanghai) 2020;52:241-50. [PMID: 32072180 DOI: 10.1093/abbs/gmz169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]